Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach

Abstract Endometrial cancer presents a major public health issue, particularly in post-menopausal women. Whilst there are known risk factors for the disease, including oestrogen and obesity, these factors do not fully explain risk variability in cancer outcomes. The identification of novel risk fact...

Full description

Saved in:
Bibliographic Details
Main Authors: Ella Fryer, Charlie Hatcher, Rochelle Knight, Kaitlin H Wade
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-96740-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726140612083712
author Ella Fryer
Charlie Hatcher
Rochelle Knight
Kaitlin H Wade
author_facet Ella Fryer
Charlie Hatcher
Rochelle Knight
Kaitlin H Wade
author_sort Ella Fryer
collection DOAJ
description Abstract Endometrial cancer presents a major public health issue, particularly in post-menopausal women. Whilst there are known risk factors for the disease, including oestrogen and obesity, these factors do not fully explain risk variability in cancer outcomes. The identification of novel risk factors may aid in better understanding of endometrial cancer development and, given the link with oestrogen metabolism, obesity and the risk of various cancers, the gut microbiome could be one such risk factor. Mendelian randomization (MR), a method that reduces biases of conventional epidemiological studies (namely, confounding and reverse causation) by using genetic variants to proxy exposures, was used to investigate the effect of gut microbial traits on endometrial cancer risk. Whilst our initial analyses showed that the presence of an unclassified group of bacteria in the Erysipelotrichaceae family increased the risk of oestrogen-dependent endometrial cancer (odds ratio (OR) per approximate doubling of the genetic liability to presence vs. absence: 1.13; 95% CI 1.01, 1.26; P = 0.03), subsequent sensitivity analyses, including colocalisation, provided insufficient evidence to support causality. This work highlights the importance of using a robust MR analysis pipeline, including sensitivity analyses to assess the validity of causal effect estimates obtained using MR.
format Article
id doaj-art-085d664ec00b420ca2a0a9ef8181d4ea
institution DOAJ
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-085d664ec00b420ca2a0a9ef8181d4ea2025-08-20T03:10:17ZengNature PortfolioScientific Reports2045-23222025-04-0115111310.1038/s41598-025-96740-xExploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approachElla Fryer0Charlie Hatcher1Rochelle Knight2Kaitlin H Wade3MRC Integrative Epidemiology Unit, University of BristolMRC Integrative Epidemiology Unit, University of BristolMRC Integrative Epidemiology Unit, University of BristolMRC Integrative Epidemiology Unit, University of BristolAbstract Endometrial cancer presents a major public health issue, particularly in post-menopausal women. Whilst there are known risk factors for the disease, including oestrogen and obesity, these factors do not fully explain risk variability in cancer outcomes. The identification of novel risk factors may aid in better understanding of endometrial cancer development and, given the link with oestrogen metabolism, obesity and the risk of various cancers, the gut microbiome could be one such risk factor. Mendelian randomization (MR), a method that reduces biases of conventional epidemiological studies (namely, confounding and reverse causation) by using genetic variants to proxy exposures, was used to investigate the effect of gut microbial traits on endometrial cancer risk. Whilst our initial analyses showed that the presence of an unclassified group of bacteria in the Erysipelotrichaceae family increased the risk of oestrogen-dependent endometrial cancer (odds ratio (OR) per approximate doubling of the genetic liability to presence vs. absence: 1.13; 95% CI 1.01, 1.26; P = 0.03), subsequent sensitivity analyses, including colocalisation, provided insufficient evidence to support causality. This work highlights the importance of using a robust MR analysis pipeline, including sensitivity analyses to assess the validity of causal effect estimates obtained using MR.https://doi.org/10.1038/s41598-025-96740-xGut microbiomeEndometrial cancerMendelian randomization
spellingShingle Ella Fryer
Charlie Hatcher
Rochelle Knight
Kaitlin H Wade
Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach
Scientific Reports
Gut microbiome
Endometrial cancer
Mendelian randomization
title Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach
title_full Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach
title_fullStr Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach
title_full_unstemmed Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach
title_short Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach
title_sort exploring the causal role of the human gut microbiome in endometrial cancer a mendelian randomization approach
topic Gut microbiome
Endometrial cancer
Mendelian randomization
url https://doi.org/10.1038/s41598-025-96740-x
work_keys_str_mv AT ellafryer exploringthecausalroleofthehumangutmicrobiomeinendometrialcanceramendelianrandomizationapproach
AT charliehatcher exploringthecausalroleofthehumangutmicrobiomeinendometrialcanceramendelianrandomizationapproach
AT rochelleknight exploringthecausalroleofthehumangutmicrobiomeinendometrialcanceramendelianrandomizationapproach
AT kaitlinhwade exploringthecausalroleofthehumangutmicrobiomeinendometrialcanceramendelianrandomizationapproach